QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,622 signal articles · 310 in last 24h · 112,499 total before filter · latest 1h ago
310last 24h
2111last 7d
371● bullish (7d)
179● bearish (7d)
204publishers
AllMacro300Earnings1190M&A91Regulatory23Product13Analyst20
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Is Alphabet (GOOGL) Still One of the Best AI Stocks to Own?
Insider Monkey2d agoneutral
Is Alphabet (GOOGL) Still One of the Best AI Stocks to Own?

Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory’s Global Leaders Strategy delivered a net return of 4.6% in the second quarter of 2026, underperforming its benchmark, the MSCI ACWI Net Index, […]

Why ASML Holding (ASML) Could Be the Biggest AI Chip Enabler
Insider Monkey2d agoneutral
Why ASML Holding (ASML) Could Be the Biggest AI Chip Enabler

Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory’s Global Leaders Strategy delivered a net return of 4.6% in the second quarter of 2026, underperforming its benchmark, the MSCI ACWI Net Index, […]

Why Taiwan Semiconductor (TSM) Could Be a Top AI Infrastructure Winner
Insider Monkey2d agoneutral
Why Taiwan Semiconductor (TSM) Could Be a Top AI Infrastructure Winner

Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory’s Global Leaders Strategy delivered a net return of 4.6% in the second quarter of 2026, underperforming its benchmark, the MSCI ACWI Net Index, […]

HPE shares jump 5% as Morgan Stanley upgrade points to nearly 30% upside
InvestorsHub2d agobullish
HPE shares jump 5% as Morgan Stanley upgrade points to nearly 30% upside

HP Enterprise (NYSE:HPE) shares climbed 5% in Monday’s pre-market trading after Morgan Stanley upgraded the enterprise technology company from “Equalweight” to “Overweight,” citing an increasingly attractive outlook for earnings, cash generation and valuation. The investment bank set a $69 price target on HPE.

3 Large-Cap Stocks with Promising Prospects
StockStory2d agoneutral
3 Large-Cap Stocks with Promising Prospects

Large-cap stocks are known for their staying power and ability to weather market storms better than smaller competitors. However, their sheer size makes it more challenging to maintain high growth rates as they’ve already captured significant portions of their markets.

Hedge Funds are Piling Back Into the Market
The Wall Street Journal2d agoneutral
Hedge Funds are Piling Back Into the Market

The smart money on Wall Street is betting on this current bull run. After aggressively pulling back from the market just a couple weeks ago, hedge funds are piling back in. They bought global equities for a second straight week in the five trading days through last Thursday, according to a note from Goldman Sachs' prime brokerage unit.

Boeing Deal Lifts Archer Aviation
The Wall Street Journal2d agoneutral
Boeing Deal Lifts Archer Aviation

Archer Aviation is taking off. Shares in the California-based startup rose more than 20% in premarket trading after Boeing agreed to take a minority stake in the company as part of a deal that hands over control of its flying-taxi venture Wisk Aero.

AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results
InvestorsHub2d agobullish
AbCellera shares surge 22% after ABCL635 delivers positive Phase 2 results

AbCellera (NASDAQ:ABCL) shares jumped 22% on Monday after the biotechnology company announced positive topline results from a Phase 2 clinical trial evaluating ABCL635 as a potential treatment for moderate-to-severe vasomotor symptoms associated with menopause. The study achieved its primary efficacy endpoints, demonstrating statistically significant reductions in both the frequency and severity of moderate-to-severe vasomotor symptoms at week four following a single dose compared with placebo.

Investing.com2d agobearish
Intel stock stumbles following blockbuster $15 billion equity offering

Investing.com -- Intel Corporation (NASDAQ:INTC) shares dipped 3.3% after the chipmaker dropped a surprise announcement: a proposed $15 billion underwritten public offering of common stock. While the massive capital raise will dilute current shareholders, Intel’s leadership is framing it as a strategic power move. The company plans to funnel the net proceeds directly into general corporate coffers, heavy-duty capital expenditures, and day-to-day working capital to fuel its ongoing turnaround. Ma

1 Healthcare Stock Worth Your Attention and 2 We Ignore
StockStory2d agoneutral
1 Healthcare Stock Worth Your Attention and 2 We Ignore

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 18.3% over the past six months, topping the S&P 500 by 7.4 percentage points.

Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Insider Monkey2d agoneutral
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?

Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J’s MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon […]

1 Software Stock to Own for Decades and 2 We Question
StockStory2d agoneutral
1 Software Stock to Own for Decades and 2 We Question

Software is eating the world, and virtually no business is left untouched by it. The undeniable tailwinds fueling the industry have also led to strong returns for SaaS stocks lately as they’ve gained 30.3% over the past six months, outpacing the S&P 500’s 10.9% rise.

SpaceX Stock Jumps Again After Lock-Up Rally. When’s the Next Release, What to Expect.
Barrons.com2d agobullish
SpaceX Stock Jumps Again After Lock-Up Rally. When’s the Next Release, What to Expect.

SpaceX stock was jumping again in Monday’s premarket—on pace for its highest close for a month, after snapping a 4-week losing run on Friday with a 16% surge following the end of a lockup period for shares. The Elon Musk-led satellite and AI company’s shares were rising 4% to $138.57 as investors regained appetite for the stock after a torrid time since its closing high of $201.80 on June 16—reached two days after its IPO on June 12. Wall Street had widely braced for severe selling pressure on Thursday, when SpaceX’s first lockup expiration freed roughly 911 million restricted insider shares.